Small Mobile Stem Cell Culture and Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating and culturing stem cells, particularly small mobile stem (SMS) cells, face challenges in maintaining them in an undifferentiated state for prolonged periods and directing their differentiation into specific cell types, which is crucial for regenerative medicine applications.

Innovation Solution

A method involving culturing SMS cells in suspension using a high sugar basal medium with calf serum and insulin, at 37°C and 5% CO2, in vessels that prevent adherence, such as polypropylene, and employing centrifugation and filtration to isolate undifferentiated SMS cells, followed by induction with chemical agents to produce desired molecules or ECM proteins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If stem cells are cultured using conventional methods, then cell growth occurs, but the cells differentiate into mature cell types and cannot be maintained in an undifferentiated state for prolonged periods

Engineering Contradiction:
Improveduration of undifferentiated state maintenanceVSAvoidcell differentiation state
Core Design Contradiction:
Duration of action of stationary objectVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by modifying culture conditions including using high sugar basal medium with specific concentrations of calf serum and insulin, controlling temperature at 37°C, maintaining 5% CO2 atmosphere, and using suspension culture in polypropylene vessels. These parameter changes enable maintenance of SMS cells in an undifferentiated state for extended periods while preventing unwanted differentiation.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If stem cells are isolated from tissue samples, then pure stem cell populations can be obtained, but the isolation process is complex and time-consuming

Engineering Contradiction:
Improvepurity of stem cell populationVSAvoidisolation procedure complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs centrifugation and filtration methods that allow the cell population to self-separate based on physical properties. Undifferentiated SMS cells are isolated through density centrifugation and size-based filtration without requiring complex immunomagnetic sorting or multiple purification steps, simplifying the isolation procedure while maintaining population purity.

Inventive Principle:
Principle #25Self-service

3Productivity

If stem cells are directed to differentiate into specific cell types, then functional cells for tissue repair can be produced, but control over the differentiation pathway is difficult

Engineering Contradiction:
Improveproduction of specific cell typesVSAvoidcontrol of differentiation
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The patent uses chemical agents to pre-commit SMS cells to specific differentiation pathways before full differentiation occurs. By exposing undifferentiated or early-differentiating cells to specific chemical inducers, the differentiation trajectory is established early, enabling more predictable and controllable production of target cell types compared to attempting to direct fully differentiated cells.

Inventive Principle:
Principle #10Preliminary action

4Adaptability or versatility

If embryonic stem cells are used for regenerative therapy, then cells can differentiate into all cell types, but ethical controversies and immune rejection issues arise

Engineering Contradiction:
Improvedifferentiation potentialVSAvoidethical and immune issues
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the desirable differentiation potential of embryonic stem cells by using SMS cells that can be autologously obtained from the patient's own bone marrow or peripheral blood. This extraction approach eliminates the ethical controversies and immune rejection problems associated with embryonic stem cells while retaining the ability to differentiate into multiple cell types needed for regenerative therapy.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the maintenance of SMS cells in an undifferentiated state for extended periods, facilitating their use in producing various molecules and ECM proteins, which can be applied in wound healing and tissue engineering.

Implementation Method 1

culturing SMS cells in suspension using a high sugar basal medium with calf serum and insulin

Methodology Applied
Scientific EffectCell culture:

Implementation Method 2

employing centrifugation and filtration to isolate undifferentiated SMS cells

Methodology Applied
Scientific EffectCentrifugation: Centrifugal Force

Implementation Method 3

employing centrifugation and filtration to isolate undifferentiated SMS cells

Methodology Applied
Scientific EffectFiltration: Filter (physical)

Implementation Method 4

followed by induction with chemical agents to produce desired molecules or ECM proteins

Methodology Applied
Scientific EffectChemical induction:

Data Source

PatentUS20250109385A1Compositions and methods for using small mobile stem cells
Publication Date: 2025.04.03 SMSBIOTECH INC
  • US20250109385A1 patent drawing
  • US20250109385A1 patent drawing
  • US20250109385A1 patent drawing

AI summary

Disclosed herein are small mobile stem (SMS) cells and methods of culturing, isolating, and using SMS cells. Also disclosed are methods of culturing SMS cells in an undifferentiated state for prolonged periods of time, and for using SMS cells for the production of a variety of molecules, including proteins, extracellular matrix (ECM) proteins, and the use of SMS cells in microfluidic devices